Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli

GÖKGÖZ, AZİZE BÜŞRA; Yilmaz Can, Emine

doi:10.29058/mjwbs.928899

Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli

Azize Büşra GÖKGÖZ, (Zonguldak Bülent Ecevit Üniversitesi, Sağlık Bilimleri Enstitüsü, Tıbbi Farmakoloji Anabilim Dalı, Zonguldak, Türkiye)

Emine Yilmaz Can (Zonguldak Bülent Ecevit Üniversitesi, Tıp Fakültesi, Tıbbi Farmakoloji Anabilim Dalı, Zonguldak, Türkiye)

Batı Karadeniz Tıp Dergisi

9 4

Yıl: 2021 Cilt: 5 Sayı: 3 Sayfa Aralığı: 315 - 323 Metin Dili: Türkçe DOI: 10.29058/mjwbs.928899 İndeks Tarihi: 15-08-2022

Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli

Öz:

Kenevir bitkisi, endüstri ve tıp gibi temel alanlarda kolay, ekonomik ve sağlıklı çözümler sunan bir bitkidir. Başta kannabinoidler olmak üzere çok sayıda kimyasal madde içermektedir ve zengin bir ürün yelpazesi vardır. Endüstriyel kenevir biyobozunur her çeşit plastik madde, kağıt-karton, ısı yalıtım ve inşaat malzemeleri üretiminde, tekstil ve otomotiv sektöründe, gıda ve kozmetik ürünlerin imalatında ve biyodizel üretiminde kullanılmaktadır. Medikal kenevir kemoterapiye bağlı bulantı-kusma, kanser ile ilişkili nöropatik ağrı, multipl skleroz ile ilişkili spastisitede, HIV’li hastalarda kilo alımında ve epilepsi gibi bazı hastalıkların tedavisinde kullanılmaktadır. Bu yazıda, eski uygarlıklar tarafından kullanılmış olup kültürümüzde önemli bir yere sahip olan ve son yıllarda popülerlik kazanan tıbbi ve endüstriyel kenevir bitkisinin dünden bugüne kullanımı, yetiştirilmesi, tıp ve endüstrideki yeri hakkında bilgi verilmesi ve aynı zamanda kenevirin ekonomik potansiyelinin ortaya koyulması amaçlanmıştır.

Anahtar Kelime: Endüstriyel Kenevir Medikal Kenevir Kannabinoidler Endokannabinoid Sistem Kannabidiol THC

The Importance of Cannabinoids in Medical and Industrial Perspectives and Potential Contribution to Turkey’s Economy

Öz:

Cannabis is a plant that offers easy, economical and healthy solutions in basic areas such as industry and medicine. It contains a large number of chemicals, mainly cannabinoids, and has a rich product range. Industrial hemp is used in the production of all kinds of biodegradable plastic materials, in the production of paper-cardboard, in the production of thermal insulation and construction materials, in the textile industry, in the automotive industry, in the manufacture of food and cosmetic products, in the production of biodiesel. Medical cannabis is used for nausea-vomiting due to chemotherapy, neuropathic pain associated with cancer, spasticity associated with multiple sclerosis, weight gain in patients with HIV and in the treatment of some diseases such as epilepsy. In this article, it is aimed to give information about the usage and cultivation of the medical and industrial cannabis plant, which has an important place in our culture, which has been used even by ancient civilizations that have gained popularity in recent years, and also to reveal the potential of cannabis.

Anahtar Kelime: Industrial Hemp Medical Hemp Cannabinoids Endocannabinoid System Cannabidiol THC

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1. Tanker N, Koyuncu M, Coşkun M. Fam: Cannabinace. Farmasötik Botanik. 3. Basım. Ankara, Ankara Üniversitesi Basımevi; 2007. 184-185.
2. Pisanti S, Bifulco M. Medical Cannabis: A plurimillennial history of an evergreen. J Cell Physiol 2019; 234: 8342-8351.
3. McPartland JM. Cannabis systematics at the levels of family, genus, and species. Cannabis Cannabinoid Res 2018; 3: 203- 212.
4. Flores-Sanchez IJ, Verpoorte R. Secondary metabolism in cannabis. Phytochem Rev 2008; 7: 615-639.
5. Kisková T, Mungenast F, Suváková M, Jäger W, Thalhammer T. Future aspects for cannabinoids in breast cancer therapy. Int J Mol Sci 2019; 20: 1-21.
6. Vogel E. Hemp (Cannabis sativa L.) for medicinal purposes: Cultivation under German growing conditions. Project in Organic Agriculture and Food Systems 2016/2017; 654524: 1-29.
7. Pellati F, Borgonetti V, Brighenti V, Biagi M, Benvenuti S, Corsi L. Cannabis sativa L. and nonpsychoactive cannabinoids: Their chemistry and role against oxidative stress, inflammation, and cancer. Biomed Res Int 2018; 2018: 1-15.
8. Clarke RC, Merlin MD. Cannabis domestication, breeding history, present-day genetic diversity, and future prospects. Critic Rev in Plant Sci 2016; 35: 293-327.
9. Chandra S, Radwan MM, Majumdar CG, Church JC, Freeman TP, ElSohly MA. New trends in cannabis potency in USA and Europe during the last decade (2008-2017). Eur Arch Psychiatry Clin Neurosci 2019; 269: 5-15.
10. Hand A, Blake A, Kerrigan PJ, Samuel P. History of medical cannabis. J Pain Manage 2016; 9: 387-394.
11. Brand EJ, Zhao Z. Cannabis in chinese medicine: Are some traditional indications referenced in ancient literature related to cannabinoids? Front Pharmacol 2017; 8: 1-11.
12. Salentijn EMJ, Zhang Q, Amaducci S, Yang M, Trindade LM. New developments in fiber hemp (Cannabis sativa L.) breeding. Ind Crop Product 2015; 68: 32-41.
13. Bonini SA, Premoli M, Tambaro S, Kumar A, Maccarinelli G, Memo M, Mastinu A. Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. J Ethnopharmacol 2018; 227: 300-315.
14. Sharma VK, Chandel A, Acharya G, Deshmukh R. Endocan- nabinoid system: Neuropharmacological implications. Med Sci 2016; 5: 562-82.
15. Gaoni, Y, Mechoulam R. Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 1964; 86: 1646-1647.
16. Mechoulam R, Hanuš LO, Pertwee R, Howlett AC. Early phytocannabinoid chemistry to endocannabinoids and beyond. Nat Rev Neurosci 2014; 15: 757-764.
17. Tüfekçi Alphan E, Yılmaz N. Endokanabinoid sistemin, enerji metabolizması ve obeziteye etkisi. Marmara Med J 2007; 20: 202-214.
18. Bozkurt TE. Endocannabinoid system in the airways. Molecules 2019; 24: 1-16.
19. Zou S, Kumar U. Cannabinoid receptors and the endocanna- binoid system: Signaling and function in the central nervous system. Int J Mol Sci 2018; 19: 1-23.
20. Le Boisselier R, Alexandre J, Lelong-Boulouard V, Debruyne D. Focus on cannabinoids and synthetic cannabinoids. Clin Pharmacol Ther 2017; 101: 220-229.
21. Ulugöl A. The endocannabinoid system as a potential therapeutic target for pain modulation. Balkan Med J 2014; 31: 115-120.
22. Śledziński P, Zeyland J, Słomski R, Nowak A. The current state and future perspectives of cannabinoids in cancer biology. Cancer Med 2018; 7: 765-775.
23. Tamba BI, Stanciu GD, Urîtu CM, Rezus E, Stefanescu R, Mihai CT, Luca A, Rusu-Zota G, Leon-Constantin MM, Cojocaru E, Gafton B, Alexa-Stratulat T. Challenges and opportunities in preclinical research of synthetic cannabinoids for pain therapy. Medicina (Kaunas) 2020; 56: 1-22.
24. Maurya N, Velmurugan BK. Therapeutic applications of cannabinoids. Chem Biol Interact 2018; 293: 77-88.
25. Scuderi C, Filippis DD, Iuvone T, Blasio A, Steardo A, Esposito G. Cannabidiol in medicine: A review of its therapeutic potential in cns disorders. Phytother Res 2009; 23; 597-602.
26. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 2003; 42: 327-360.
27. Narouze S, Strand N, Roychoudhury P. Cannabinoids-based medicine pharmacology, drug interactions, and perioperative management of surgical patients. Adv Anesth 2020; 38: 167- 188.
28. Sholler DJ, Huestis MA, Amendolara B, Vandrey R, Cooper ZD. Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids. Pharmacol Biochem Behav 2020; 199: 1-11.
29. Ronan PJ, Wongngamnit N, Beresford TP. Molecular mechanisms of cannabis signaling in the brain. Prog Mol Biol Transl Sci 2016; 137: 123-147.
30. Stampanoni Bassi M, Sancesario A, Morace R, Centonze D, Iezzi E. Cannabinoids in parkinson’s disease. Cannabis Cannabinoid Res 2017; 2: 21-29.
31. Battista N, Di Tommaso M, Bari M, Maccarrone M. The endocannabinoid system: An overview. Front Behav Neurosci 2012; 6: 1-7.
32. Patil AS, Mahajan UB, Agrawal YO, Patil KR, Patil CR, Ojha S, Sharma C, Goyal SN. Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review. Biomed Pharmacother 2020; 132: 1-9.
33. Andrade AK, Renda B, Murray JE. Cannabinoids, interoception, and anxiety. Pharmacol Biochem Behav 2019; 180: 60-73.
34. Lu HC, Mackie K. An introduction to the endogenous cannabinoid system. Biol Psychiatry 2016; 79: 516-525.
35. Fisar Z. Phytocannabinoids and endocannabinoids. Curr Drug Abuse Rev 2009; 2: 51-75.
36. Lucas CJ, Galettis P, Schneider J. The pharmacokinetics and the pharmacodynamics of cannabinoids. Br J Clin Pharmacol 2018; 84: 2477-2482.
37. Angelina A, Pérez-Diego M, López-Abente J, Palomares O. The role of cannabinoids in allergic diseases: Collegium internationale allergologicum (cıa) update 2020. Int Arch Allergy Immunol 2020; 181:565-584.
38. Borowska M, Czarnywojtek A, Sawicka-Gutaj N, Woliński K, Płazińska MT, Mikołajczak P, Ruchała M. The effects of cannabinoids on the endocrine system. Endokrynol Pol 2018; 69: 705-719.
39. Fraguas Sanchez AI, Torres Suarez AI. Medical use of cannabinoids. Drugs 2018; 78: 1665-1703.
40. Suryadevara U, Bruijnzeel DM, Nuthi M, Jagnarine DA, Tandon R, Bruijnzeel AW. Pros and cons of medical cannabis use by people with chronic brain disorders. Curr Neuropharmacol 2017; 15: 800-814.
41. Parmar JR, Forrest BD, Freeman RA. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs. Res Social Adm Pharm 2016; 12: 638-654.
42. Frassinetti S, Moccia E, Caltavuturo L, Gabriele M, Longo V, Bellani L, Giorgi G, Giorgetti L. Nutraceutical potential of hemp (Cannabis sativa L.) seeds and sprouts. Food Chem 2018; 262: 56-66.
43. Gao C, Xin P, Cheng C, Tang Q, Chen P, Wang C, Zang G, Zhao L. Diversity analysis in cannabis sativa based on large- scale development of expressed sequence tag-derived simple sequence repeat markers. Plos One 2014; 9: 1-7.
44. Spitzer-Rimon B, Duchin S, Bernstein N, Kamenetsky R. Architecture and florogenesis in female cannabis sativa plants. Front Plant Sci 2019; 10: 1-11.
45. Karche T, Singh MR. The application of hemp (Cannabis sativa L.) for a green economy: A review. Turk J Bot 2019; 43: 710- 723.
46. Schluttenhofer C, Yuan L. Challenges towards revitalizing hemp: A multifaceted crop. Trends Plant Sci 2017; 22: 917-929.
47. Bernstein N, Gorelick J, Koch S. Interplay between chemistry and morphology in medical cannabis (Cannabis sativa L.). Ind Crop Product 2019; 129: 185-194.
48. Rehman MSU, Rashid N, Saif A, Mahmood T, Han JI. Potential of bioenergy production from industrial hemp (Cannabis sativa): Pakistan perspective. Renew Sustain Energy Rev 2013; 18: 154-164.
49. Väisänen T, Paolo Batello, Reijo Lappalainen, Laura Tomppo. Modification of hemp fibers (Cannabis Sativa L.) for composite applications. Ind Crop Product 2018; 111: 422-429.
50. Manaia JP, Manaia AT, Rodriges L. Industrial hemp fibers: An overview. Fibers 2019;7:1-16.
51. Tutuş A, Çiçekler M. Pulp and paper production from hemp by modified kraft method. 1st International Mediterranean Science and Engineering Congress (IMSEC 2016). Adana, Turkey, October 26-28, 2016, 1036-1042.
52. Ascrizzi R, Ceccarini L, Tavarini S, Flamini G. Valorisation of hemp inflorescence after seed harvest: Cultivation site and harvest time influence agronomic characteristics and essential oil yield and composition. Ind Crop Product 2019;139:1-8.
53. Gül S, Kıvrak B. Kültür coğrafyası bağlamında vezirköprü’de kendircilik ve urgancılık. Uluslararası Afro-avrasya Araştırmaları Dergisi 2018;3:201-219.
54. Tiret JS. Hemp (Cannabis sativa L.) cultivation in north-central Turkey. J Ind Hemp 2008;7:73-81.
55. Kurtuldu E, Erdem İşmal Ö. Sürdürülebilir tekstil üretim ve tasarımında yeniden değer kazanan lif: Kenevir. SDÜ art-e Güzel Sanatlar Fakültesi Sanat Dergisi 2019; 12: 694-718.

APA	GÖKGÖZ A, Yilmaz Can E (2021). Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli. , 315 - 323. 10.29058/mjwbs.928899
Chicago	GÖKGÖZ AZİZE BÜŞRA,Yilmaz Can Emine Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli. (2021): 315 - 323. 10.29058/mjwbs.928899
MLA	GÖKGÖZ AZİZE BÜŞRA,Yilmaz Can Emine Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli. , 2021, ss.315 - 323. 10.29058/mjwbs.928899
AMA	GÖKGÖZ A,Yilmaz Can E Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli. . 2021; 315 - 323. 10.29058/mjwbs.928899
Vancouver	GÖKGÖZ A,Yilmaz Can E Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli. . 2021; 315 - 323. 10.29058/mjwbs.928899
IEEE	GÖKGÖZ A,Yilmaz Can E "Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli." , ss.315 - 323, 2021. 10.29058/mjwbs.928899
ISNAD	GÖKGÖZ, AZİZE BÜŞRA - Yilmaz Can, Emine. "Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli". (2021), 315-323. https://doi.org/10.29058/mjwbs.928899

APA	GÖKGÖZ A, Yilmaz Can E (2021). Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli. Batı Karadeniz Tıp Dergisi, 5(3), 315 - 323. 10.29058/mjwbs.928899
Chicago	GÖKGÖZ AZİZE BÜŞRA,Yilmaz Can Emine Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli. Batı Karadeniz Tıp Dergisi 5, no.3 (2021): 315 - 323. 10.29058/mjwbs.928899
MLA	GÖKGÖZ AZİZE BÜŞRA,Yilmaz Can Emine Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli. Batı Karadeniz Tıp Dergisi, vol.5, no.3, 2021, ss.315 - 323. 10.29058/mjwbs.928899
AMA	GÖKGÖZ A,Yilmaz Can E Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli. Batı Karadeniz Tıp Dergisi. 2021; 5(3): 315 - 323. 10.29058/mjwbs.928899
Vancouver	GÖKGÖZ A,Yilmaz Can E Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli. Batı Karadeniz Tıp Dergisi. 2021; 5(3): 315 - 323. 10.29058/mjwbs.928899
IEEE	GÖKGÖZ A,Yilmaz Can E "Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli." Batı Karadeniz Tıp Dergisi, 5, ss.315 - 323, 2021. 10.29058/mjwbs.928899
ISNAD	GÖKGÖZ, AZİZE BÜŞRA - Yilmaz Can, Emine. "Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli". Batı Karadeniz Tıp Dergisi 5/3 (2021), 315-323. https://doi.org/10.29058/mjwbs.928899